Arsenal Capital Partners (“Arsenal”), a leading private equity firm that invests in middle-market specialty industrials and healthcare business services companies, announced today the acquisition of Epoxy Technology, Inc. (“Epoxy Tech”), a leading manufacturer of high-performance specialty epoxy, ultraviolet, and hybrid adhesives.
Earlier this week, Arsenal announced the creation of Meridian Adhesives Group (“Meridian”) as its new platform in adhesives and sealants and the concurrent acquisition of Adhesives Technology Corporation, a leading specialty manufacturer of adhesives for the infrastructure and construction industries.
“Everyone at Epoxy Tech is very excited about this new opportunity. We look forward to expanding the company’s ability to deliver premium adhesive products to our customers, and we feel fortunate to work with a partner such as Arsenal given its proven, significant experience in the specialty adhesives industry,” said Andy Horne, the President of Epoxy Tech.
Roy Seroussi, an Investment Partner of Arsenal said, “Epoxy Tech has a long history of innovation. The acquisition of Epoxy Tech represents a further step in Arsenal’s strategy to build a leading adhesives and sealants business, offering customized and proprietary solutions to a global customer base.”
Don Nolan, interim CEO of Meridian and the Chair of the board, said, “We look forward to the partnership with Epoxy Tech’s management and employees. Our strategy is to grow Epoxy Tech organically and through acquisitions to expand Meridian’s portfolio of great products.”
Arsenal brings significant experience in the $60 billion global adhesives and sealants market, having previously built Royal Adhesives and Sealants through nine strategic acquisitions and creating a top ten global supplier of adhesives and sealants with sales in excess of $600 million annually.
Source: Arsenal Capital Partners
This equipment will significantly lower the site’s CO2 emissions, reduce flaring and save around 60 gigawatt hours (GWh) energy each year. Project kick-off is in February 2021, with completion planned for 2023.
The acquisition significantly strengthens and expands Grace’s existing pharma portfolio. Pharma & Consumer is the largest, fastest growing and most profitable subsegment within Grace’s Materials Technologies business.
Solvay says it has decided to organize its soda ash and derivatives business into a separate and fully controlled legal structure.